During the past decade, Elbe Klinikum Buxtehude conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 12 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 9 clinical trials were completed. i.e. 450% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Elbe Klinikum Buxtehude" #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Prof. Dr. med. Dirk Schadendorf" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "Hoffmann-La Roche" with 2 trials sponsored and "Incyte Corporation" with 2 trials sponsored. Other sponsors include 13 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Elbe Klinikum Buxtehude" #1 collaborator was "Bristol-Myers Squibb" with 2 trials as a collaborator, "Sanofi" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Alcedis GmbH" with 1 trials as a collaborator and "Boehringer Ingelheim" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.

According to Clinical.Site data, the most researched conditions in "Elbe Klinikum Buxtehude" are "Atopic Dermatitis" (5 trials), "Melanoma" (5 trials), "Psoriasis" (3 trials), "Basal Cell Carcinoma" (2 trials) and "Joint Disease" (2 trials). Many other conditions were trialed in "Elbe Klinikum Buxtehude" in a lesser frequency.

Most popular intervention types in "Elbe Klinikum Buxtehude" are "Drug" (25 trials), "Biological" (6 trials), "Device" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Nivolumab" (4 trials), "Ipilimumab" (2 trials), "Mirikizumab" (2 trials) and "Nivolumab + Ipilimumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Elbe Klinikum Buxtehude" are 33 trials for "All" genders.

Currently, there are NaN active trials in "Elbe Klinikum Buxtehude". undefined are not yet recruiting, 5 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 15 completed trials in Elbe Klinikum Buxtehude, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Elbe Klinikum Buxtehude, 1 "Phase 1" clinical trials were conducted, 14 "Phase 2" clinical trials and 13 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".

Elbe Klinikum Buxtehude has several departments that took part in Clinical trials: "Elbekliniken Buxtehude; Klinik für Dermatologie" - 3 trials